Corbus Pharmaceuticals Holdings, Inc.

CRBP

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001193125-26-091647
Filing date: Mar 4, 2026
Earliest execution date: Mar 2, 2026

Summary

Type

Sell

Net shares

-6,097

% of shares

-6.36%

Amount (USD)

$50,601

Insider confidence score

42.5 out of 100

Positive

  • Tax withholding obligation

Negative

  • Large tax withholding sell (≥1% of shares)
  • Significant sell amount ($50K+)

Stock transactions

Transaction 1

Security

Common Stock, par value $0.0001 per share

Action

Sell

Date

2026-03-02

Code

S

Net shares

-6,097.0

Price per Share

$8.30

Amount (USD)

$50,601.44

Acquired/Disposed

Disposed

Shares Owned Before

95,887.0

Shares Owned After

89,790.0

Filing's footnotes

1. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.20 to $8.35. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. This amount includes 73,765 unvested RSUs subject to each grant's vesting schedule as previously reported.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.